Medi Help Line   Report issue

For profit Phase 2
Founded: Seoul Korea, Republic of (1998)

Organization Overview

First Clinical Trial
2020
NCT04220762
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Medi Help Line

Active Ingredients

Drugs in Phase 2 Trials (1)

win-1001x (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1